We observed a negative enrichment of this gene set upon MLL1 and MLL2 downregulation, which implies that MLL1 and/or MLL2 are involved in the positive regulation of these transcription factors, and thus might contribute to the maintenance of glioma stemness (Fig. 1H). This evidence concerns the gene KMT2A and central nervous system cancer.